- £196.16bn
- £215.32bn
- $54.07bn
- 85
- 17
- 83
- 70
REG - AstraZeneca PLC - IRESSA approved by US FDA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementFDA REVIEWS SAVOR OUTCOMES STUDY RESULTS
AnnouncementTremelimumab granted Orphan Drug Designation
AnnouncementREG - AstraZeneca PLC - Agreement with Tillotts on Entocort <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Change in ADS ratio <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Publication of Prospectus <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AstraZeneca PLC - Blocklisting Interim Review <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding - Replacement <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director Declaration <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
Announcement